abstract |
The present invention relates to novel immunogenic polypeptides, and therapeutically active fragments thereof, and vaccines, and vaccine compositions, for the prevention and treatment of streptococcal infection, especially by Streptococcus pneumoniae . The invention also relates to antibodies against the disclosed polypeptides, as well as methods of disease prevention and/or treatment. |